Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

14 Sep 2011
Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

12 Sep 2011
Scientists successfully disrupt function of MYC cancer gene

Scientists successfully disrupt function of MYC cancer gene

12 Sep 2011
LC-MRM could provide better understanding of multiple myeloma drug resistance

LC-MRM could provide better understanding of multiple myeloma drug resistance

12 Sep 2011
Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

9 Sep 2011
9/11 firefighters at greater risk of cancer

9/11 firefighters at greater risk of cancer

2 Sep 2011
Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

31 Aug 2011
Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

30 Aug 2011
Patrys product shows activity in multiple myeloma cancer cells

Patrys product shows activity in multiple myeloma cancer cells

16 Aug 2011
Amorfix provides update on cancer therapeutic antibody programs

Amorfix provides update on cancer therapeutic antibody programs

12 Aug 2011
NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

10 Aug 2011
Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study

Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study

9 Aug 2011
Keryx reports net loss of $3.1 million for second quarter 2011

Keryx reports net loss of $3.1 million for second quarter 2011

8 Aug 2011
YM BioSciences reports preclinical results of CYT387 in multiple myeloma

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

5 Aug 2011
ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

4 Aug 2011
ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

4 Aug 2011
Celgene reports second quarter total revenue of $1.18 billion

Celgene reports second quarter total revenue of $1.18 billion

28 Jul 2011
Recruitment complete in Aeterna Zentaris' perifosine Phase 3 trial for advanced colorectal cancer

Recruitment complete in Aeterna Zentaris' perifosine Phase 3 trial for advanced colorectal cancer

27 Jul 2011
Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

27 Jul 2011
TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

26 Jul 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback